131 related articles for article (PubMed ID: 8988040)
1. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.
Seckl MJ; Higgins T; Widmer F; Rozengurt E
Cancer Res; 1997 Jan; 57(1):51-4. PubMed ID: 8988040
[TBL] [Abstract][Full Text] [Related]
2. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
[TBL] [Abstract][Full Text] [Related]
4. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Woll PJ; Rozengurt E
Cancer Res; 1990 Jul; 50(13):3968-73. PubMed ID: 1693879
[TBL] [Abstract][Full Text] [Related]
5. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
Seckl MJ; Higgins T; Rozengurt E
J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
[TBL] [Abstract][Full Text] [Related]
6. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.
MacKinnon AC; Armstrong RA; Waters CM; Cummings J; Smyth JF; Haslett C; Sethi T
Br J Cancer; 1999 Jun; 80(7):1026-34. PubMed ID: 10362111
[TBL] [Abstract][Full Text] [Related]
7. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
8. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.
Reeve JG; Bleehen NM
Biochem Biophys Res Commun; 1994 Mar; 199(3):1313-9. PubMed ID: 7511895
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells.
Matsumoto Y; Kawatani M; Simizu S; Tanaka T; Takada M; Imoto M
Anticancer Res; 2000; 20(5A):3123-9. PubMed ID: 11062732
[TBL] [Abstract][Full Text] [Related]
10. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells.
Sethi T; Rozengurt E
Cancer Res; 1992 Nov; 52(21):6031-5. PubMed ID: 1327522
[TBL] [Abstract][Full Text] [Related]
11. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
12. Galanin stimulates Ca2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells.
Sethi T; Rozengurt E
Cancer Res; 1991 Mar; 51(6):1674-9. PubMed ID: 1705478
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
Everard MJ; Macaulay VM; Miller JL; Smith IE
Br J Cancer; 1992 Mar; 65(3):388-92. PubMed ID: 1373071
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
16. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
Beekman A; Helfrich B; Bunn PA; Heasley LE
Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
[TBL] [Abstract][Full Text] [Related]
17. Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition.
Waters CM; MacKinnon AC; Cummings J; Tufail-Hanif U; Jodrell D; Haslett C; Sethi T
Br J Cancer; 2003 Jun; 88(11):1808-16. PubMed ID: 12771999
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
[TBL] [Abstract][Full Text] [Related]
19. Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu mice.
Jones DA; MacLellan AJ; Cummings J; Ritchie AA; Langdon SP; Smyth JF
Peptides; 1997; 18(7):1073-7. PubMed ID: 9357069
[TBL] [Abstract][Full Text] [Related]
20. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a neuropeptide antagonist, blocks binding, Ca2(+)-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells.
Fabregat I; Rozengurt E
J Cell Physiol; 1990 Oct; 145(1):88-94. PubMed ID: 1698796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
